Tag: Gilead Sciences
Kite Pharma, Launched by Israeli Scientists, Gets FDA Approval for Lymphoma Treatment
The Yescarta therapy will cost $373,000 for a one-time dose, which will surely become a major issue of concern for insurance companies and public health officials.
Gilead Sciences to Acquire Israeli Cancer Curing Kite Pharma for $11.9 Billion
Kite Pharma has developed engineered cell therapies that express either a chimeric antigen receptor (CAR) or an engineered T cell receptor (TCR), depending on the type of cancer.
Gilead Sciences to Open Office in Israel
Biotech giant and cash-rich Gilead Sciences will open a marketing office in Israel, Globes Business news reported, making the company the first new generation...